U.S. Food and Drug Administration Approved 30% More Drugs in 2012

RDInvesting Provides Stocks Research on Affymax and Incyte

Continue Reading

Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success

RDInvesting Provides Stocks Research on NPS Pharmaceuticals and Oncothyreon

Continue Reading

Oil Industry to Benefit From Growing Global Oil Demand in 2013

Five Star Equities Provides Stock Research on Denbury Resources and Talisman Energy

Continue Reading

Positive Outlook for Oil Industry in 2013 as EIA and OPEC Raise Forecasts for Global Oil Demand

Five Star Equities Provides Stock Research on Hercules Offshore and Seadrill

Continue Reading

Resurgence in Japanese Demand Will Look to Boost Uranium Prices in 2013

RDInvesting Provides Stock Research on Cameco and Uranium Resources

Continue Reading

U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous

Research Driven Investing Provides Stocks Research on Cytokinetics and Pluristem Therapeutics

Continue Reading

Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High

RDInvesting Provides Stocks Research on United Therapeutics and Viropharma

Continue Reading

Improvements in the Global Economy to Drive Global Demand for Oil Higher in 2013

Five Star Equities Provides Stock Research on Enerplus and Gran Tierra Energy

Continue Reading

U.S. Oil Production Hits Highest Level in 20 Years, Projected to Increase an Additional 14% in 2013

Five Star Equities Provides Stock Research on Precision Drilling and Pioneer Energy Services

Continue Reading

Solar Industry Impressing Investors With Gains in 2013 After a Dismal 2012

RDInvesting Provides Stock Research on LDK Solar and JinkoSolar

Continue Reading